Patents by Inventor Natalie Ann Borgos
Natalie Ann Borgos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230414906Abstract: Devices and methods for delivering treatment fluids or particulates such as, stem cells, drugs, Botox and like, to an inner lining of a bladder for treatment of urinary tract disorders, including over-active bladder. A balloon delivery system can include an inflation balloon having a plurality of micro-needles configured to pierce and otherwise puncture an inner bladder wall so as to deliver the treatment fluid to bladder tissue. The treatment fluid can be directly injected into the bladder tissue using the micro needles. Alternatively, the micro needles can be fabricated of bioabsorbable or bioresorbable materials such that the micro needles can remain embedded within the bladder tissue to deliver the treatment fluid or particulate.Type: ApplicationFiled: September 12, 2023Publication date: December 28, 2023Inventors: Carrie Lee Herman, Natalie Ann Borgos, Kari L. Cierzan
-
Patent number: 11806494Abstract: Systems and methods of localizing or delivery cells, biologics and/or drugs to a specific target area to treat pelvic health disorders are provided. A treatment composition including cells, biologics and/or drugs are associated with magnetic particulates, and the positioning of these materials is facilitated through use of a magnetic field-generating device that is configured to be placed on or into a pelvic anatomical structure. Certain embodiments directed to the treatment of ED in male patients can include a cell based therapy system.Type: GrantFiled: April 15, 2021Date of Patent: November 7, 2023Assignee: Boston Scientific Scimed, Inc.Inventors: Natalie Ann Borgos, Tania M. Schroeder, David J. Yonce, Robert E. Lund, Suranajan Roychowdhury
-
Patent number: 11786706Abstract: Devices and methods for delivering treatment fluids or particulates such as, stem cells, drugs, Botox and like, to an inner lining of a bladder for treatment of urinary tract disorders, including over-active bladder. A balloon delivery system can include an inflation balloon having a plurality of micro-needles configured to pierce and otherwise puncture an inner bladder wall so as to deliver the treatment fluid to bladder tissue. The treatment fluid can be directly injected into the bladder tissue using the micro needles. Alternatively, the micro needles can be fabricated of bioabsorbable or bioresorbable materials such that the micro needles can remain embedded within the bladder tissue to deliver the treatment fluid or particulate.Type: GrantFiled: February 6, 2020Date of Patent: October 17, 2023Assignee: Boston Scientific Scimed, Inc.Inventors: Carrie Lee Herman, Natalie Ann Borgos, Kari L. Cierzan
-
Publication number: 20220304842Abstract: An implantable fluid operated device may include a fluid reservoir configured to hold fluid, an inflatable member, and a pump assembly configured to transfer fluid between the fluid reservoir and the inflatable member. The pump assembly may include one or more fluid pumps and one or more valves. An electronic control system may control operation of the pump assembly based on fluid pressure measurements and/or fluid flow measurements received from the one or more sensing devices. The electronic control system may include an internal component installed with the implanted device, and an external component that is operable by a user to provide user input, and to receive output from the implanted device.Type: ApplicationFiled: March 22, 2022Publication date: September 29, 2022Inventors: Daragh Nolan, Brian P. Watschke, Noel Smith, Moira B. Sweeney, Peter Fewer, Thomas Sinnott, Richard Percy, Natalie Ann Borgos, Eduardo Marcos Larangeira, John Gildea, Evania Ann Mareena
-
Publication number: 20220304808Abstract: An implantable fluid operated device may include a fluid reservoir configured to hold fluid, an inflatable member, and a pump assembly configured to transfer fluid between the fluid reservoir and the inflatable member. The pump assembly may include one or more fluid pumps and one or more valves. The one or more valves may be normally open valves, normally closed valves, or a combination thereof. One or more sensing devices may be positioned within fluid passageways of the fluid operated device. The electronic control system may control operation of the pump assembly based on fluid pressure measurements and/or fluid flow measurements received from the one or more sensing devices. Variable voltage can be applied to the control of the pump and/or the valves based on varying atmospheric conditions and the fluid pressure and/or flow measurements processed by the electronic control system.Type: ApplicationFiled: March 22, 2022Publication date: September 29, 2022Inventors: John Gildea, Noel Smith, Eduardo Marcos Larangeira, Thomas Sinnott, Brian P. Watschke, Daragh Nolan, Natalie Ann Borgos
-
Publication number: 20210299421Abstract: Systems and methods of localizing or delivery cells, biologics and/or drugs to a specific target area to treat pelvic health disorders are provided. A treatment composition including cells, biologics and/or drugs are associated with magnetic particulates, and the positioning of these materials is facilitated through use of a magnetic field-generating device that is configured to be placed on or into a pelvic anatomical structure. Certain embodiments directed to the treatment of ED in male patients can include a cell based therapy system.Type: ApplicationFiled: April 15, 2021Publication date: September 30, 2021Inventors: Natalie Ann Borgos, Tania M. Schroeder, David J. Yonce, Robert E. Lund, Suranajan Roychowdhury
-
Patent number: 11007357Abstract: Systems and methods of localizing or delivery cells, biologics and/or drugs to a specific target area to treat pelvic health disorders are provided. A treatment composition including cells, biologics and/or drugs are associated with magnetic particulates, and the positioning of these materials is facilitated through use of a magnetic field-generating device that is configured to be placed on or into a pelvic anatomical structure. Certain embodiments directed to the treatment of ED in male patients can include a cell based therapy system.Type: GrantFiled: August 14, 2018Date of Patent: May 18, 2021Assignee: Boston Scientific Scimed, Inc.Inventors: Natalie Ann Borgos, Tania M. Schroeder, David J. Yonce, Robert E. Lund, Suranajan Roychowdhury
-
Publication number: 20200171280Abstract: Devices and methods for delivering treatment fluids or particulates such as, stem cells, drugs, Botox and like, to an inner lining of a bladder for treatment of urinary tract disorders, including over-active bladder. A balloon delivery system can include an inflation balloon having a plurality of micro-needles configured to pierce and otherwise puncture an inner bladder wall so as to deliver the treatment fluid to bladder tissue. The treatment fluid can be directly injected into the bladder tissue using the micro needles. Alternatively, the micro needles can be fabricated of bioabsorbable or bioresorbable materials such that the micro needles can remain embedded within the bladder tissue to deliver the treatment fluid or particulate.Type: ApplicationFiled: February 6, 2020Publication date: June 4, 2020Inventors: Carrie Lee Herman, Natalie Ann Borgos, Kari L. Cierzan
-
Patent number: 10589070Abstract: Devices and methods for delivering treatment fluids or particulates such as, stem cells, drugs, Botox and like, to an inner lining of a bladder for treatment of urinary tract disorders, including over active bladder. A balloon delivery system can include an inflation balloon having a plurality of micro-needles configured to pierce and otherwise puncture an inner bladder wall so as to deliver the treatment fluid to bladder tissue. The treatment fluid can be directly injected into the bladder tissue using the micro needles. Alternatively, the micro needles can be fabricated of bioabsorbable or bioresorbable materials such that the micro needles can remain embedded within the bladder tissue to deliver the treatment fluid or particulate.Type: GrantFiled: December 16, 2011Date of Patent: March 17, 2020Assignee: Boston Scientific Scimed, Inc.Inventors: Carrie Lee Herman, Natalie Ann Borgos, Kari L. Cierzan
-
Patent number: 10426585Abstract: Various embodiments of an implant system for treating fecal incontinence are provided. The devices and systems can include a mesh or like device that can include a variable porosity to control the degree of expansion of the anal canal. The mesh can be constructed at least in part of patterned strut members allowing for various geometric configurations, with varying load and tension properties for the designated portions of the device according to the needs for a particular patient application.Type: GrantFiled: July 25, 2016Date of Patent: October 1, 2019Assignee: Boston Scientific Scimed, Inc.Inventors: John R. Frigstad, Amanda J. Heys, Benjamin Y. Arcand, Natalie Ann Borgos, William A. Sturos, Daniel R. Parks
-
Publication number: 20180353741Abstract: Systems and methods of localizing or delivery cells, biologics and/or drugs to a specific target area to treat pelvic health disorders are provided. A treatment composition including cells, biologics and/or drugs are associated with magnetic particulates, and the positioning of these materials is facilitated through use of a magnetic field-generating device that is configured to be placed on or into a pelvic anatomical structure. Certain embodiments directed to the treatment of ED in male patients can include a cell based therapy system.Type: ApplicationFiled: August 14, 2018Publication date: December 13, 2018Inventors: Natalie Ann Borgos, Tania M. Schroeder, David J. Yonce, Robert E. Lund, Suranajan Roychowdhury
-
Patent number: 10076647Abstract: Systems and methods of localizing or delivery cells, biologics and/or drugs to a specific target area to treat pelvic health disorders are provided. A treatment composition including cells, biologics and/or drugs are associated with magnetic particulates, and the positioning of these materials is facilitated through use of a magnetic field-generating device that is configured to be placed on or into a pelvic anatomical structure. Certain embodiments directed to the treatment of ED in male patients can include a cell based therapy system.Type: GrantFiled: June 5, 2017Date of Patent: September 18, 2018Assignee: Boston Scientific Scimed, Inc.Inventors: Natalie Ann Borgos, Tania M. Schroeder, David J. Yonce, Robert E. Lund, Suranajan Roychowdhury
-
Publication number: 20170266425Abstract: Systems and methods of localizing or delivery cells, biologics and/or drugs to a specific target area to treat pelvic health disorders are provided. A treatment composition including cells, biologics and/or drugs are associated with magnetic particulates, and the positioning of these materials is facilitated through use of a magnetic field-generating device that is configured to be placed on or into a pelvic anatomical structure. Certain embodiments directed to the treatment of ED in male patients can include a cell based therapy system.Type: ApplicationFiled: June 5, 2017Publication date: September 21, 2017Inventors: Natalie Ann Borgos, Tania M. Schroeder, David J. Yonce, Robert E. Lund, Suranajan Roychowdhury
-
Patent number: 9675677Abstract: The invention relates to systems and therapeutic methods to reduce plaque causing Peyronie's disease. One approach uses high pressure injection of collagenase-containing composition into a penile plaque. Plaque disruption is enhanced by the mechanical force of the high pressure, followed by the enzymatic action of collagenase. Another approach uses collagenase as a pretreatment, followed by addition of adipose-derived stem cells ADSCs. The initial collagenase injection breaks down collagen (often more type III than type I in Peyronie's) to provide short term benefit. The longer-term benefit is provided by introduction of ADSCs to the plaque, which can produce cytokines and other signals for revascularization, and restoration of normal penile tissue. The resulting combination advantageously reduces the bulk of the plaque early on with ongoing reduction through the revascularization of the tissue. In addition, the treatment provides an advantageous shift of elastin and collagen ratios.Type: GrantFiled: November 3, 2015Date of Patent: June 13, 2017Assignee: Boston Scientific Scimed, Inc.Inventor: Natalie Ann Borgos
-
Patent number: 9669200Abstract: Systems and methods of localizing or delivery cells, biologics and/or drugs to a specific target area to treat pelvic health disorders are provided. A treatment composition including cells, biologics and/or drugs are associated with magnetic particulates, and the positioning of these materials is facilitated through use of a magnetic field-generating device that is configured to be placed on or into a pelvic anatomical structure. Certain embodiments directed to the treatment of ED in male patients can include a cell based therapy system.Type: GrantFiled: August 8, 2011Date of Patent: June 6, 2017Assignee: Boston Scientific Scimed, Inc.Inventors: Natalie Ann Borgos, Tania M. Schroeder, David J. Yonce, Robert E. Lund, Suranajan Roychowdhury
-
Publication number: 20160331502Abstract: Various embodiments of an implant system for treating fecal incontinence are provided. The devices and systems can include a mesh or like device that can include a variable porosity to control the degree of expansion of the anal canal. The mesh can be constructed at least in part of patterned strut members allowing for various geometric configurations, with varying load and tension properties for the designated portions of the device according to the needs for a particular patient application.Type: ApplicationFiled: July 25, 2016Publication date: November 17, 2016Inventors: John R. Frigstad, Amanda J. Heys, Benjamin Y. Arcand, Natalie Ann Borgos, William A. Sturos, Daniel R. Parks
-
Patent number: 9402704Abstract: Various embodiments of an implant system for treating fecal incontinence are provided. The devices and systems can include a mesh or like device that can include a variable porosity to control the degree of expansion of the anal canal. The mesh can be constructed at least in part of patterned strut members allowing for various geometric configurations, with varying load and tension properties for the designated portions of the device according to the needs for a particular patient application.Type: GrantFiled: August 30, 2012Date of Patent: August 2, 2016Assignee: Boston Scientific Scimed, Inc.Inventors: John R. Frigstad, Amanda J. Heys, Benjamin Y. Arcand, Natalie Ann Borgos, William A. Sturos, Daniel R. Parks
-
Publication number: 20160051642Abstract: The invention relates to systems and therapeutic methods to reduce plaque causing Peyronie's disease. One approach uses high pressure injection of collagenase-containing composition into a penile plaque. Plaque disruption is enhanced by the mechanical force of the high pressure, followed by the enzymatic action of collagenase. Another approach uses collagenase as a pretreatment, followed by addition of adipose-derived stem cells ADSCs. The initial collagenase injection breaks down collagen (often more type III than type I in Peyronie's) to provide short term benefit. The longer-term benefit is provided by introduction of ADSCs to the plaque, which can produce cytokines and other signals for revascularization, and restoration of normal penile tissue. The resulting combination advantageously reduces the bulk of the plaque early on with ongoing reduction through the revascularization of the tissue. In addition, the treatment provides an advantageous shift of elastin and collagen ratios.Type: ApplicationFiled: November 3, 2015Publication date: February 25, 2016Inventor: Natalie Ann Borgos
-
Patent number: 9180172Abstract: The invention relates to systems and therapeutic methods to reduce plaque causing Peyronie's disease. One approach uses high pressure injection of collagenase-containing composition into a penile plaque. Plaque disruption is enhanced by the mechanical force of the high pressure, followed by the enzymatic action of collagenase. Another approach uses collagenase as a pretreatment, followed by addition of adipose-derived stem cells ADSCs. The initial collagenase injection breaks down collagen (often more type III than type I in Peyronie's) to provide short term benefit. The longer-term benefit is provided by introduction of ADSCs to the plaque, which can produce cytokines and other signals for revascularization and restoration of normal penile tissue. The resulting combination advantageously reduces the bulk of the plaque early on with ongoing reduction through the revascularization of the tissue. In addition, the treatment provides an advantageous shift of elastin and collagen ratios.Type: GrantFiled: December 15, 2011Date of Patent: November 10, 2015Assignee: AMS RESEARCH CORPORATIONInventor: Natalie Ann Borgos
-
Publication number: 20130331783Abstract: Devices and methods for delivering treatment fluids or particulates such as, stem cells, drugs, Botox and like, to an inner lining of a bladder for treatment of urinary tract disorders, including over active bladder. A balloon delivery system can include an inflation balloon having a plurality of micro-needles configured to pierce and otherwise puncture an inner bladder wall so as to deliver the treatment fluid to bladder tissue. The treatment fluid can be directly injected into the bladder tissue using the micro needles. Alternatively, the micro needles can be fabricated of bioabsorbable or bioresorbable materials such that the micro needles can remain embedded within the bladder tissue to deliver the treatment fluid or particulate.Type: ApplicationFiled: December 16, 2011Publication date: December 12, 2013Applicant: AMS RESEARCH CORPORATIONInventors: Carrie Lee Herman, Natalie Ann Borgos, Kari L. Cierzan